Republicans block cap on insulin costs for millions
of patients
https://www.washingtonpost.com/nation/2022/08/07/insulin-cap-budget-congress/
https://www.washingtonpost.com/nation/2022/08/07/insulin-cap-budget-congress/
Democrats’ Long-Sought Plan for Lowering Drug Costs
Is at Hand
https://www.nytimes.com/2022/08/05/us/politics/medicare-drug-costs.html
Empowering Medicare to negotiate prices directly with drug makers has been a Democratic goal for 30 years, one the pharmaceutical industry has fought ferociously.
My take:
https://www.nytimes.com/2022/08/05/us/politics/medicare-drug-costs.html
Empowering Medicare to negotiate prices directly with drug makers has been a Democratic goal for 30 years, one the pharmaceutical industry has fought ferociously.
My take:
Health care and higher education: Key
drivers of long-term inflation by Vivekanand Jayakumar | The Hill, 01/31/22
https://thehill.com/opinion/finance/591995-health-care-and-higher-education-key-drivers-of-long-term-inflation/
There is a role for well-thought-out fiscal interventions to boost efficiency and competition in the health care sector. Reforming the U.S. patent system and making the federal government a more effective negotiator that can leverage its role as a large-scale purchaser to attain lower pharmaceutical drug prices are low hanging fruit that can be plucked with bipartisan support if the Big Pharma lobby can be kept at bay.
https://thehill.com/opinion/finance/591995-health-care-and-higher-education-key-drivers-of-long-term-inflation/
There is a role for well-thought-out fiscal interventions to boost efficiency and competition in the health care sector. Reforming the U.S. patent system and making the federal government a more effective negotiator that can leverage its role as a large-scale purchaser to attain lower pharmaceutical drug prices are low hanging fruit that can be plucked with bipartisan support if the Big Pharma lobby can be kept at bay.
Related:
The U.S. Can Lower Drug Prices Without Sacrificing Innovation
https://www.commonwealthfund.org/blog/2021/us-can-lower-drug-prices-without-sacrificing-innovation
Drug Innovation: When Patents Work (and When They Don’t)
https://www.milkenreview.org/articles/drug-innovation-when-patents-work
Our patent system is broken. And it could be stifling innovation.
https://www.washingtonpost.com/outlook/2021/08/08/our-patent-system-is-broken-it-could-be-stifling-innovation/
Are drug patents worth it? | The Economist
https://www.economist.com/business/2021/05/15/are-drug-patents-worth-it
https://www.commonwealthfund.org/blog/2021/us-can-lower-drug-prices-without-sacrificing-innovation
Drug Innovation: When Patents Work (and When They Don’t)
https://www.milkenreview.org/articles/drug-innovation-when-patents-work
Our patent system is broken. And it could be stifling innovation.
https://www.washingtonpost.com/outlook/2021/08/08/our-patent-system-is-broken-it-could-be-stifling-innovation/
Are drug patents worth it? | The Economist
https://www.economist.com/business/2021/05/15/are-drug-patents-worth-it